Diabetes Complications and the Risk of Cardiovascular and Cerebrovascular Diseases

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSecond Affiliated Hospital, School of Medicine, Zhejiang University

About this trial

This study is intended to include 3000 diabetic patients in our hospital to collect complete medical history data, comprehensively improve the screening of diabetic complications and cardiovascular and cerebrovascular risk assessment.

Eligibility criteria

Qualifiers

Diabetic symptoms with: plasma glucose level at any time ≥11.1mmol/ L (200mg/ dL), or Fasting plasma glucose level ≥7.0mmol/ L (126mg/ dL), or plasma glucose level ≥11.1mmol/ L (200ng/ dL) for 2 h in OGTT test, or HbA1c ≥6.5%; Or those without typical symptoms should repeated the tests in another day.

Han Chinese.

Willingness to participate.

Disqualifiers

Secondary diabetes.

Participants in other clinical trials.

Trial design

Treatments tested in this trial

  • no intervention

Treatment groups

3,000 Participants
are divided into 1 treatment group